MD2, Cystatin C and DNA Methylation Tags as Serum Biomarkers for POCD. (BM-POCD)
Serum Biomarkers for Prediction and Diagnosis of POCD in Elderly Patients Undergoing Cardiac Surgery.
Sponsor: Xijing Hospital
This observational or N/A phase trial investigates Postoperative Cognitive Dysfunction and is currently ongoing. Xijing Hospital leads this study, which shows 12 recorded versions since 2018 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Sep 2022 — Jul 2024 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Dec 2021 — Sep 2022 [monthly]
Recruiting
-
Jan 2021 — Dec 2021 [monthly]
Recruiting
▶ Show 7 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Aug 2020 — Nov 2020 [monthly]
Recruiting
-
Feb 2019 — Aug 2020 [monthly]
Recruiting
-
Dec 2018 — Feb 2019 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Nov 2018 — Dec 2018 [monthly]
Not Yet Recruiting
-
Oct 2018 — Nov 2018 [monthly]
Not Yet Recruiting
-
Aug 2018 — Oct 2018 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Xijing Hospital
For direct contact, visit the study record on ClinicalTrials.gov .